Research study Program year 2020 Source: CMS Open Payments

Menb Rec 2Nd Gen-023 (V72_57)

Research payments

$5,474,163

1,737 payments

Through program year 2020, $5,474,163 in research payments was reported against Menb Rec 2Nd Gen-023 (V72_57), across 1,737 payments, paid by GlaxoSmithKline, LLC..

Paid by: GlaxoSmithKline, LLC.
ClinicalTrials.gov: No trial number was reported for this study

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$2,664,422	777
2019	Research	$2,809,741	960

Breakdown

Who paid Research payments · program years 2019–2020

GlaxoSmithKline, LLC. $5,474,163 1,737 payments

Who received the money Research payments · program years 2019–2020

Kaiser Foundation Research Institute Organisation paid for research $2,931,510 360 payments
Creighton University Medical Center Organisation paid for research $429,093 186 payments
University of Pittsburgh Physicians Organisation paid for research $164,743 64 payments
Pharmaceutical Research Organization Organisation paid for research $115,107 76 payments
Palmetto Pediatrics Organisation paid for research $112,438 75 payments
Upmc General Surgery Organisation paid for research $110,048 53 payments
The Research Foundation For The State University Of New York Organisation paid for research $94,576 29 payments
Kentucky Pediatric And Adultresearch Organisation paid for research $87,231 55 payments
Asr LLC Organisation paid for research $85,581 39 payments
Childrens Clinic Organisation paid for research $85,003 34 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

9 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.